What is GRNQ's health score?

Greenpro Capital Corp. (GRNQ) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GRNQ's estimated fair value?

Based on our 5-year discounted cash flow model, Greenpro Capital Corp.'s estimated fair value is $0.77 per share, representing a -44.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GRNQ undervalued or overvalued?

Our model currently rates GRNQ as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

Greenpro Capital Corp. (GRNQ)

Industrials Overvalued low weak

$1.38

Updated: 2026-07-16

TradeApes Score

Financial Strength

30 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk Management

80 Strong

Est. Fair Value $0.77

DCF Upside -44.3%

Sector Rank #908 of 7242

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

Acco Group Holdings Ltd (ACCL) ACCESS Newswire Inc. (ACCS) Aeries Technology, Inc. (AERT) Aeries Technology, Inc. (AERTW) Atlantis Glory Inc. (AGLY) ALE Group Holding Ltd (ALEH)

See all Industrials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.